Submission Details
| 510(k) Number | K251495 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2025 |
| Decision Date | August 13, 2025 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K251495 is an FDA 510(k) clearance for the MBT Compass HT CA Software; MBT FAST Shuttle US IVD, a Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates (Class II — Special Controls, product code QBN), submitted by Bruker Daltonics GmbH & Co. KG (Bremen, DE). The FDA issued a Cleared decision on August 13, 2025, 90 days after receiving the submission on May 15, 2025. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3378.
| 510(k) Number | K251495 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 15, 2025 |
| Decision Date | August 13, 2025 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QBN — Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3378 |
| Definition | The Maldi Biotyper Ca System Is A Mass Spectrometer System Using Matrix-assisted Laser Desorption/ionization - Time Of Flight (maldi-tof) For The Identification And Differentiation Of Microorganisms Cultured From Human Specimens. The Maldi Biotyper Ca System Is A Qualitative In Vitro Diagnostic Device Indicated For Use In Conjunction With Other Clinical And Laboratory Findings To Aid In The Diagnosis Of Bacterial And Fungal Infections. |